Primary Myelofibrosis Recruiting Phase 2 Trials for Cefotaxime (DB00493)

Also known as: Myelofibrosis, Primary / Osteomyelofibrosis / Chronic idiopathic myelofibrosis

IndicationStatusPhase
DBCOND0001581 (Primary Myelofibrosis)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs